The therapy I'm referring to is called CAR T cell therapy.The medicines authority approved it, the FDA in 2017 and 2018, by the European Medicines Agency EMA.Lymphomas are neoplasms of the immune system.The most frequent are so-called non-Hodgkin's lymphomas, most of which are derived from cells called B cells. These are the cells that, in... Continue Reading →